Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Poised for phase 3, Galera's GC4419 wards off radiation side effects

fiercebiotechAugust 21, 2018

Tag: Galera's GC4419 , radiation side effects

PharmaSources Customer Service